Yüklüyor......
Early Bortezomib Therapy for Refractory Anti-NMDA Receptor Encephalitis
Introduction: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an increasingly recognized form of immune-mediated encephalitis. Here we present a case that represents the shortest hospitalization-to-bortezomib treatment timeline (42 days), and we believe that this is reflected in the patien...
Kaydedildi:
| Yayımlandı: | Front Neurol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7118211/ https://ncbi.nlm.nih.gov/pubmed/32292386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00188 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|